Skip to content
Open access

White matter lesions disrupt cholinergic transmission to impact cognition in Parkinson's disease.

Sep 2026 · Brain : a journal of neurology · 0 citations
Medicine

Abstract

This scientific commentary refers to ‘White matter lesions disrupt cholinergic pathways important for cognition in Parkinson’s disease’ by Carli et al. (https://doi.org/10.1093/brain/awag172).

Read PDF

Similar papers

Open access Sep 2026

Post mortem MRI of cholinergic white matter pathways across neurodegenerative diseases

Cholinergic white matter pathway degeneration is central in Alzheimer's disease and Lewy body disease and can be assessed in vivo using magnetic resonance imaging proxies, but neuropathological validation is limited.

F. López-González, M. Němý, C. Jerele et al. · 0 citations
Open access Sep 2026

Dopaminergic‐ and Cholinergic‐Related Structural MRI Patterns Across Cognitive Subtypes of Parkinson's Disease With Mild Cognitive Impairment

The dual syndrome hypothesis distinguishes frontostriatal and posterior cortical cognitive subtypes in Parkinson's disease with mild cognitive impairment (PD‐MCI), which are associated with distinct cognitive profiles and different risks of dementia.

Xue-Qin Bai, Hao-Xin Chen, Qiu-Yue Li et al. · 0 citations
Open access Aug 2026

State‐Specific Segmental Abnormalities of White Matter Structure and Function in Pediatric Bipolar Disorders

White matter (WM), as the critical infrastructure for neural communication, is implicated in pediatric bipolar disorder (PBD) pathophysiology. However, the state‐specific abnormalities in the segmental structural and functional properties of adolescent fiber tracts remain unclear.

Zi-Qi Chen, Weijia Gao, Ruhai Dou et al. · 0 citations
Open access Aug 2026

Female vulnerability to microvascular transport dysfunction emerges early across the Alzheimer's disease continuum

We tested whether quantitative transport mapping (QTM)‐derived perfusion velocity would detect earlier and more sex‐specific microvascular alterations than cerebral blood flow (CBF) across the Alzheimer's disease (AD) continuum.

Man-Xi Xu, Yian Gao, Pei-Ling Ou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.